Compumedics Ltd - Asset Resilience Ratio
Compumedics Ltd (CMP) has an Asset Resilience Ratio of 16.97% as of June 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check CMP capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2022)
This chart shows how Compumedics Ltd's Asset Resilience Ratio has changed over time. See Compumedics Ltd balance sheet independence to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Compumedics Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Compumedics Ltd (CMP) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$7.08 Million | 16.97% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$7.08 Million | 16.97% |
Asset Resilience Insights
- Good Liquidity Position: Compumedics Ltd maintains a healthy 16.97% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Compumedics Ltd Industry Peers by Asset Resilience Ratio
Compare Compumedics Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Inspire Medical Systems Inc
NYSE:INSP |
Medical Devices | 20.29% |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186 |
Medical Devices | 0.84% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Stratec SE
XETRA:SBS |
Medical Devices | 0.30% |
|
Duearity AB
ST:DEAR |
Medical Devices | 145.62% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Annual Asset Resilience Ratio for Compumedics Ltd (2016–2022)
The table below shows the annual Asset Resilience Ratio data for Compumedics Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-06-30 | 16.97% | AU$7.08 Million ≈ $5.01 Million |
AU$41.71 Million ≈ $29.51 Million |
+5.08pp |
| 2019-06-30 | 11.90% | AU$4.60 Million ≈ $3.25 Million |
AU$38.66 Million ≈ $27.36 Million |
+0.62pp |
| 2018-06-30 | 11.27% | AU$3.91 Million ≈ $2.76 Million |
AU$34.65 Million ≈ $24.52 Million |
-2.76pp |
| 2017-06-30 | 14.03% | AU$4.10 Million ≈ $2.90 Million |
AU$29.23 Million ≈ $20.68 Million |
-- |
| 2016-06-30 | 0.00% | AU$0.00 ≈ $0.00 |
AU$26.12 Million ≈ $18.48 Million |
-- |
About Compumedics Ltd
Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients' physiological data; Somté PSG; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST… Read more